Agree Realty Reports Strong Q1 Growth with 19% EPS Increase and $404M in Acquisitions

summarizeSummary

Agree Realty reported strong first-quarter results, including a 19% increase in EPS and a 33% rise in net income, alongside $404.3 million in property acquisitions and a robust $2.28 billion liquidity position.

check_boxKey Events

• Strong Q1 Financial Performance

  Net income attributable to common stockholders increased 33% to $60.2 million, and basic and diluted EPS rose 19% to $0.50 per share for the three months ended March 31, 2026, compared to the prior year period. Core FFO per diluted share also increased by 8.7% to $1.13.

• Significant Property Acquisitions

  The company acquired 85 properties for a total purchase price of $404.3 million during the first quarter of 2026, expanding its portfolio to 2,756 properties across all 50 states.

• Robust Liquidity Position

  Agree Realty reported over $2.28 billion in liquidity as of March 31, 2026, comprising cash, unsettled forward equity, undrawn capacity under its 2031 Term Loan, and availability under its Revolving Credit Facility.

• Capital Program Updates

  The company sold 8,738,029 shares under its At-The-Market (ATM) programs in Q1 2026 through forward sale agreements, with no net proceeds received yet. Additionally, a follow-on public offering from April 2025 for 5,175,000 shares, anticipated to raise $384.5 million, remains unsettled.

auto_awesomeAnalysis

Agree Realty Corporation's Q1 2026 10-Q filing confirms robust financial performance, with significant year-over-year growth in key metrics. The company's strategic focus on acquiring high-quality retail properties continues to drive expansion, as evidenced by substantial acquisition activity during the quarter. The strong liquidity position provides a solid foundation for ongoing growth initiatives and operational stability. While some top-line results were concurrently reported by news outlets, this detailed filing provides comprehensive financial statements and operational insights crucial for investors to assess the company's health and future prospects.